Abiopharma

🔍 Foyle Jennifer M. (Executive)

Company: AMERICAN EAGLE OUTFITTERS INC (AEO)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 23,161 shares of Common Stock, without par value (Direct)
  Date: 2026-03-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 310,888.00 | transaction_form_type: 4
• Sold 12,809 shares of Common Stock, without par value at $16.09 per share (Direct)
  Date: 2026-03-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 298,079.00 | transaction_form_type: 4
• Sold 1,900 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-03-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,452.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 21,261 shares of Restricted Stock Unit (Derivative)
  Date: 2026-03-30 | Code: M | Expires: 2026-03-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The dividend equivalent rights accrued on previously awarded restricted stock units (RSUs) which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of American Eagle Outfitters common stock.
• F2: Each restricted stock unit represents a contingent right to receive one share of American Eagle Outfitters common stock.
• F3: The restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant.